{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:24:25Z","timestamp":1790882665558,"version":"4.1.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Ovidius University of Constanta","award":["UOC 14449\/21 October"],"award-info":[{"award-number":["UOC 14449\/21 October"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,23]]},"abstract":"<jats:p>Recent research highlights a potential link between metabolic dysfunction\u2013associated steatotic liver disease (MASLD) and intestinal barrier dysfunction. Increased intestinal permeability (IP) may facilitate the translocation of bacteria, endotoxins (e.g., lipopolysaccharides [LPS]), and pathogen-associated molecular patterns into the portal venous system, fostering a pro-inflammatory environment and contributing to liver inflammation. This study aimed to identify correlations between intestinal barrier biomarkers (occludin, LPS, and intestinal-type fatty-acid-binding proteins [I-FABP]) and MASLD. A single-center prospective cross-sectional study was conducted, including 72 MASLD patients and 68 healthy controls. Fibroscan-controlled attenuation parameter (CAP) was performed in all subjects. Blood samples were analyzed for biochemical parameters, and serum levels of occludin, LPS, and I-FABP were measured using the ELISA method with the Human occludin, LPS, and I-FABP ELISA Kit test systems (FineTest, Wuhan, China). LPS and I-FABP levels were significantly higher in MASLD patients compared to controls, with the highest LPS levels observed in the diabetic MASLD subgroup. Occludin levels showed no statistically significant differences between groups. All 3 biomarkers were positively correlated with BMI, with the highest levels in obese subjects. LPS was positively correlated with CRP levels. Using Fibroscan-CAP, we found a positive correlation between LPS and both liver stiffness and CAP score, as well as between I-FABP and liver stiffness. MASLD patients exhibit increased IP, with enterocyte injury present irrespective of diabetes status, though more pronounced in diabetic MASLD. Occludin does not appear to be a reliable biomarker for evaluating intestinal barrier function in MASLD. Obesity is linked to elevated biomarkers, suggesting an association between increased IP and obesity. I-FABP and LPS may serve as noninvasive biomarkers for assessing hepatic fibrosis and steatosis in MASLD patients. Notably, LPS, given its correlation with elevated CRP levels, could be utilized as a marker of disease progression and severity.<\/jats:p>","DOI":"10.1097\/md.0000000000042476","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:00:13Z","timestamp":1748318413000},"page":"e42476","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Linking gut permeability to liver steatosis: Noninvasive biomarker evaluation in MASLD patients \u2013 a prospective cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9550-3537","authenticated-orcid":false,"given":"Andrei","family":"Dumitru","sequence":"first","affiliation":[{"name":"\u201cSf. Apostol Andrei\u201d Clinical Emergency County Hospital, Constanta, Romania"},{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-0630","authenticated-orcid":false,"given":"Cristina","family":"Tocia","sequence":"additional","affiliation":[{"name":"\u201cSf. Apostol Andrei\u201d Clinical Emergency County Hospital, Constanta, Romania"},{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina-Cristina","family":"B\u0103descu","sequence":"additional","affiliation":[{"name":"\u201cSf. Apostol Andrei\u201d Clinical Emergency County Hospital, Constanta, Romania"},{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7542-2441","authenticated-orcid":false,"given":"Anamaria","family":"Trandafir","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-3549","authenticated-orcid":false,"given":"Luana","family":"Alexandrescu","sequence":"additional","affiliation":[{"name":"\u201cSf. Apostol Andrei\u201d Clinical Emergency County Hospital, Constanta, Romania"},{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan","family":"Popescu","sequence":"additional","affiliation":[{"name":"\u201cSf. Apostol Andrei\u201d Clinical Emergency County Hospital, Constanta, Romania"},{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7268-3723","authenticated-orcid":false,"given":"Eugen","family":"Dumitru","sequence":"additional","affiliation":[{"name":"\u201cSf. Apostol Andrei\u201d Clinical Emergency County Hospital, Constanta, Romania"},{"name":"Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania"},{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Academy of Romanian Scientists, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Chisoi","sequence":"additional","affiliation":[{"name":"\u201cSf. Apostol Andrei\u201d Clinical Emergency County Hospital, Constanta, Romania"},{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Medical Sciences Academy, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Manea","sequence":"additional","affiliation":[{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology, \u201cOvidius\u201d University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8554-7739","authenticated-orcid":false,"given":"Elena","family":"Matei","sequence":"additional","affiliation":[{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology, \u201cOvidius\u201d University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0202-5933","authenticated-orcid":false,"given":"Georgeta Camelia","family":"Cozaru","sequence":"additional","affiliation":[{"name":"\u201cSf. Apostol Andrei\u201d Clinical Emergency County Hospital, Constanta, Romania"},{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Medical Sciences Academy, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Rugin\u0103","sequence":"additional","affiliation":[{"name":"Academy of Romanian Scientists, Bucharest, Romania"},{"name":"Medical Sciences Academy, Bucharest, Romania"},{"name":"Clinical Hospital of Infectious Diseases, Constanta, Romania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical.","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-014-0189-7","article-title":"Intestinal permeability \u2013 a new target for disease prevention and therapy.","volume":"14","author":"Bischoff","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"98","DOI":"10.23736\/S2724-5985.20.02808-1","article-title":"the small intestine: barrier, permeability and microbiota.","volume":"68","author":"Stalla","year":"2022","journal-title":"Minerva Gastroenterol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.cgh.2013.07.001","article-title":"Intestinal permeability defects: is it time to treat?","volume":"11","author":"Odenwald","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome.","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"G413","DOI":"10.1152\/ajpgi.00361.2016","article-title":"Microbiome and host interactions: gut-liver axis at the frontier of host-microbial interactions.","volume":"312","author":"Brandl","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2147\/TCRM.S115902","article-title":"Intestinal permeability in a patient with liver cirrhosis.","volume":"12","author":"Valadez","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cld.2023.01.013","article-title":"Pathogenetic pathways in nonalcoholic fatty liver disease: an incomplete jigsaw puzzle.","volume":"27","author":"Pan","year":"2023","journal-title":"Clin Liver Dis"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3390\/diagnostics13111976","article-title":"Fecal and circulating biomarkers for the non-invasive assessment of intestinal permeability.","volume":"13","author":"Perez-Diaz-del-Campo","year":"2023","journal-title":"Diagnostics"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature.","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.14798","article-title":"Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival.","volume":"1514","author":"Kuo","year":"2022","journal-title":"Ann N Y Acad Sci"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/medicina58060760","article-title":"HPV and HIV coinfection in women from a southeast region of Romania\u2014PICOPIV Study.","volume":"58","author":"Cambrea","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/ijms25052472","article-title":"Endotoxin inflammatory action on cells by dysregulated-immunological-barrier-linked ROS-apoptosis mechanisms in gut\u2013liver axis.","volume":"25","author":"Dumitru","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0009-9120(03)00096-1","article-title":"Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility.","volume":"36","author":"Pelsers","year":"2003","journal-title":"Clin Biochem"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"32679","DOI":"10.1074\/jbc.R110.135210","article-title":"Tissue-specific functions in the fatty acid-binding protein family.","volume":"285","author":"Storch","year":"2010","journal-title":"J Biol Chem"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12986-016-0089-7","article-title":"The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity.","volume":"13","author":"Lau","year":"2016","journal-title":"Nutr Metab (Lond)"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/SLA.0b013e3181d778c4","article-title":"Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis.","volume":"251","author":"Thuijls","year":"2010","journal-title":"Ann Surg"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3109\/00365521.2011.627447","article-title":"Additional value of serum I-FABP levels for evaluating celiac disease activity in children.","volume":"46","author":"Vreugdenhil","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.12194","article-title":"Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.","volume":"37","author":"Adriaanse","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43066-023-00255-x","article-title":"Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV\/HIV co-infected patients.","volume":"13","author":"Abdelhaleem","year":"2023","journal-title":"Egypt Liver J"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/nu13051659","article-title":"Markers of intestinal permeability are rapidly improved by alcohol withdrawal in patients with alcohol-related liver disease.","volume":"13","author":"Jung","year":"2021","journal-title":"Nutrients"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"114","DOI":"10.14739\/2310-1210.2024.2.296120","article-title":"Study of fatty acid-binding protein and Bacteroidetes and Firmicutes levels in patients with metabolic-associated fatty liver disease in combination with type 2 diabetes mellitus and small intestinal bacterial overgrowth syndrome.","volume":"26","author":"Cherniavskyi","year":"2024","journal-title":"Zaporozhye Med J"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41598-017-01709-0","article-title":"Adipocyte fatty-acid binding protein is overexpressed in cirrhosis and correlates with clinical outcomes.","volume":"7","author":"Graupera","year":"2017","journal-title":"Sci Rep"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.cgh.2022.11.030","article-title":"Blood endotoxin levels as biomarker of nonalcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"21","author":"Soppert","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gutjnl-2018-317726","article-title":"Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction.","volume":"69","author":"Tulkens","year":"2020","journal-title":"Gut"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MEG.0000000000002456","article-title":"Elevated serum levels of diamine oxidase, D-lactate and lipopolysaccharides are associated with metabolic-associated fatty liver disease.","volume":"35","author":"Zhang","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-9255-7-15","article-title":"Elevated endotoxin levels in non-alcoholic fatty liver disease.","volume":"7","author":"Harte","year":"2010","journal-title":"J Inflamm (Lond)"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1872-034X.2007.00130.x","article-title":"Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis.","volume":"37","author":"Iijima","year":"2007","journal-title":"Hepatol Res"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3748\/wjg.14.6036","article-title":"Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model.","volume":"14","author":"Tsujimoto","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"770986","DOI":"10.3389\/fendo.2021.770986","article-title":"Endotoxins and non-alcoholic fatty liver disease.","volume":"12","author":"Kessoku","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update.","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhepr.2019.09.001","article-title":"Serum lipopolysaccharides predict advanced liver disease in the general population.","volume":"1","author":"M\u00e4nnist\u00f6","year":"2019","journal-title":"JHEP Rep"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1083\/jcb.138.4.891","article-title":"COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos.","volume":"138","author":"Chen","year":"1997","journal-title":"J Cell Biol"},{"key":"R37-20250527","article-title":"Multiple domains of occludin are involved in the regulation of paracellular permeability \u2013 PubMed."},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1083\/jcb.134.4.1031","article-title":"Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein.","volume":"134","author":"Balda","year":"1996","journal-title":"J Cell Biol"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1549-8719.1998.tb00069.x","article-title":"Expression of zonula occludens and adherens junctional proteins in human venous and arterial endothelian cells: role of occludin in endothelial solute barriers.","volume":"5","author":"Kevil","year":"1998","journal-title":"Microcirculation"},{"key":"R40-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications.","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"R41-20250527","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1091\/mbc.E20-07-0464","article-title":"Occludin and tricellulin facilitate formation of anastomosing tight-junction strand network to improve barrier function.","volume":"32","author":"Saito","year":"2021","journal-title":"Mol Biol Cell"},{"key":"R42-20250527","first-page":"2153","article-title":"Somatostatin regulates tight junction proteins expression in colitis mice.","volume":"7","author":"Li","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R43-20250527","doi-asserted-by":"crossref","first-page":"G988","DOI":"10.1152\/ajpgi.00256.2015","article-title":"Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.","volume":"309","author":"Nighot","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"G1140","DOI":"10.1152\/ajpgi.90534.2008","article-title":"Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.","volume":"296","author":"Mennigen","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.burnso.2020.05.005","article-title":"Intestinal permeability in participants with thermal injury: a case series from a prospective, longitudinal study (HESTIA).","volume":"4","author":"Tipple","year":"2020","journal-title":"Burns Open"},{"key":"R46-20250527","doi-asserted-by":"crossref","first-page":"103136","DOI":"10.1016\/j.msard.2021.103136","article-title":"Circulating levels of tight junction proteins in multiple sclerosis: association with inflammation and disease activity before and after disease modifying therapy.","volume":"54","author":"Olsson","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"R47-20250527","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.3390\/ijms232213675","article-title":"Microbiota dysbiosis and gut barrier dysfunction associated with non-alcoholic fatty liver disease are modulated by a specific metabolic cofactors\u2019 combination.","volume":"23","author":"Quesada-V\u00e1zquez","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R48-20250527","article-title":"Expression of intestinal tight junction proteins in patients with non-alcoholic fatty liver disease - PubMed."},{"key":"R49-20250527","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.3390\/nu14173649","article-title":"Intestinal barrier permeability in obese individuals with or without metabolic syndrome: a systematic review.","volume":"14","author":"Bona","year":"2022","journal-title":"Nutrients"},{"key":"R50-20250527","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/infdis\/jix688","article-title":"Contribution of liver fibrosis and microbial translocation to immune activation in persons infected with HIV and\/or hepatitis C virus.","volume":"217","author":"Reid","year":"2018","journal-title":"J Infect Dis"},{"key":"R51-20250527","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease.","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"R52-20250527","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.aohep.2018.09.003","article-title":"Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD).","volume":"18","author":"Tovo","year":"2019","journal-title":"Ann Hepatol"},{"key":"R54-20250527","first-page":"e17622","article-title":"Diagnostic accuracy of FIB-4 and FIB-5 scores as compared to fibroscan for assessment of liver fibrosis in patients with non-alcoholic fatty liver disease.","volume":"13","author":"Kumari","year":"2021","journal-title":"Cureus"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:00:25Z","timestamp":1748318425000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":52,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042476","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}